232 filings
Page 8 of 12
8-K
yabx3q r0tqkr46gujl
10 Feb 22
GBS Inc. Reports Second Quarter 2022 Financial Results and Recent Business Highlights
4:17pm
8-K
rz9v9itg lq5
16 Dec 21
GBS Inc. Announces Application for FDA Breakthrough Device Designation to Fast Track Rapid Saliva Glucose Test
4:05pm
8-K
3vx6viv1xrx
1 Dec 21
GBS Inc. Announces Plans for Clinical SARS-CoV-2 Antibody Trials Following Validation Study
4:05pm
8-K
qk2n8e0ck
24 Nov 21
Life Science Biosensor Diagnostics Pty Ltd Statement in Relation to Recent Sale of Shares in GBS Inc
4:05pm
8-K
7ss0g
17 Nov 21
GBS Inc. Reports First Quarter 2022 Financial Results and Recent Business Highlights
4:05pm
8-K
vf6pm72 mphe
3 Nov 21
GBS Inc. Announces Executive Leadership Changes to Accelerate Product Development and Manufacturing
5:01pm
8-K
27uqdf6k dj9cwgv0p
14 Oct 21
GBS Inc. Announces its Pre-Submission package is with the FDA
12:00pm
10-K/A
62t wklkswu6xjje3l3
30 Sep 21
Annual report (amended)
12:56pm
10-K
qaw vmydueq
16 Sep 21
Annual report
12:00am
8-K
c77yqkveybiukb
11 Aug 21
GBS Inc. Reports Fourth Quarter and Full Year 2021 Preliminary Financial Results and Recent Business Highlights
4:00pm
8-K
l00dfftbz2uzhf
15 Jun 21
Departure of Directors or Certain Officers
8:01am
8-K
yv3kqk x0
27 Apr 21
Other Events
9:00am
8-K
zbe 115li5ylhqlark
2 Apr 21
Entry into a Material Definitive Agreement
5:00pm
EFFECT
07pdx7
1 Apr 21
Notice of effectiveness
12:15am
CORRESP
71cgc8cjiac8en
29 Mar 21
Correspondence with SEC
12:00am
CORRESP
v2gn195bz 3jnjv9yvk
9 Mar 21
Correspondence with SEC
12:00am